Skip to main content
Clinical Trials/NCT01485380
NCT01485380
Completed
Not Applicable

Combined Electroencephalogram, Magnetic Resonance Imaging-Positron Emission Tomography of Dexmedetomidine Induced Sleep

Massachusetts General Hospital1 site in 1 country20 target enrollmentSeptember 2012

Overview

Phase
Not Applicable
Intervention
dexmedetomidine
Conditions
Dexmedetomidine Induced Sedation
Sponsor
Massachusetts General Hospital
Enrollment
20
Locations
1
Primary Endpoint
Number of Participants With Changes in the Brains Default Mode Network.
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The investigators are doing this research study to find out how and where dexmedetomidine, a sedative anesthetic, acts in the brain. The investigators will do this by using a machine that records the brains electrical activity, called an electroencephalogram (EEG), and brain imaging scans to look at the brain.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
July 2013
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Oluwaseun Johnson-Akeju, MD, MMSc

Assistant in Anesthaesia

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) physical status I
  • 18 to 35 years of age

Exclusion Criteria

  • MRI and/or PET screening criteria not met
  • Abnormal sleep habits/known or suspected sleep disorder(s)
  • Taking medication that alters sleep, cognitive function, or both -History of a known neurological or psychiatric problem -Younger than 18 or older than 35 years of age

Arms & Interventions

Active study arm

Subjects recruited into this study will be required to undergo two magnetic resonance imaging- positron emission tomography (MRI-PET) scans of the brain in addition to high density electroencephalogram (EEG) acquisition. The first scan will be a baseline scan while the second scan will be performed while dexmedetomidine is being infused.

Intervention: dexmedetomidine

Outcomes

Primary Outcomes

Number of Participants With Changes in the Brains Default Mode Network.

Time Frame: 1.5hrs

Number of participants with changes in the Default Mode network during loss and recovery of consciousness under dexmedetomidine induced sedation versus baseline as assessed by changes in blood oxygen level depended (BOLD) signals during the awake, unconscious, and recovery states.

Study Sites (1)

Loading locations...

Similar Trials